Roger D. Dansey
Chief Medical Officer, Seagen.
Companies
- Nurix (United States)Board member Nov 10, 2025 to now1
- Bicycle Therapeutics (United Kingdom)Board member Sep 10, 2025 to now2
- Kronos Bio, Inc.Board member Apr 24, 2023 to now3
- Inovio PharmaceuticalsBoard member May 17, 2021 to now4
- SeagenPresident Dec 16, 2022 to Dec 15, 20235
- SeagenChief Medical Officer May 31, 2018 to Nov 14, 20226
- SeagenChief executive officer Aug 17, 2022 to Oct 19, 20227
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Bicycle Therapeutics (United Kingdom) BCYC15,532 shares8$56.4K at $3.63Jan 2, 2026
Inovio Pharmaceuticals INO8,916 shares9$8.9K at $1.00May 21, 2025
Seagen SGEN0 shares10Dec 14, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 2, 2026Granted 3,032 shares of Bicycle Therapeutics (United Kingdom)8
- Sep 8, 2025Granted 12,500 shares of Bicycle Therapeutics (United Kingdom)11
- May 21, 2025Exercised options 2,167 shares of Inovio Pharmaceuticals9
- May 15, 2024Exercised options 2,166 shares of Inovio Pharmaceuticals12
- May 13, 2024Exercised options 1,000 shares of Inovio Pharmaceuticals13
- Dec 14, 2023Returned to company 38,338 shares at $229.00 of Seagen10
- Sep 21, 2023Sold 71 shares at $206.50 of Seagen14
- Aug 31, 2023Sold 4,029 shares at $206.97 of Seagen15
- Aug 29, 2023Sold 1,016 shares at $206.00 of Seagen16
- Aug 28, 2023Granted 1,872 shares of Seagen16
- Aug 16, 2023Returned to company 2,348 shares at $193.87 of Seagen17
- Aug 16, 2023Returned to company 6,100 shares at $193.87 of Seagen17
- Aug 16, 2023Returned to company 1,804 shares at $193.87 of Seagen17
- Aug 15, 2023Granted 25,747 shares of Seagen17
- May 16, 2023Exercised options 19,000 shares of Inovio Pharmaceuticals18
- May 13, 2023Exercised options 12,000 shares of Inovio Pharmaceuticals18
- Apr 17, 2023Sold 10,000 shares at $205.95 of Seagen19
- Apr 17, 2023Exercised options 10,000 shares at $72.64 of Seagen19
- Apr 6, 2023Sold 333 shares at $205.86 of Seagen20
- Apr 5, 2023Granted 3,320 shares of Seagen14
- Apr 5, 2023Granted 609 shares of Seagen20
- Apr 1, 2023Granted 2,260 shares of Seagen21
- Mar 15, 2023Sold 10,000 shares at $199.81 of Seagen22
- Mar 15, 2023Exercised options 10,000 shares at $72.64 of Seagen22
- Mar 13, 2023Granted 1,660 shares of Seagen14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNurix (United States), Board member
- 2
- 3SEC EDGARKronos Bio, Inc., Board member
- 4SEC EDGARInovio Pharmaceuticals, Board member
- 5SEC EDGARSeagen, President
- 6SEC EDGARSeagen, Chief Medical Officer
- 7SEC EDGARSeagen, Chief executive officer
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Sep 10, 2025
- 12SEC EDGARForm 4 filed May 16, 2024
- 13SEC EDGARForm 4 filed May 13, 2024
- 14SEC EDGARForm 4 filed Sep 22, 2023
- 15SEC EDGARForm 4 filed Sep 1, 2023
- 16SEC EDGARForm 4 filed Aug 30, 2023
- 17SEC EDGARForm 4 filed Aug 17, 2023
- 18SEC EDGARForm 4 filed May 16, 2023
- 19SEC EDGARForm 4 filed Apr 19, 2023
- 20SEC EDGARForm 4 filed Apr 7, 2023
- 21SEC EDGARForm 4 filed Apr 4, 2023
- 22SEC EDGARForm 4 filed Mar 17, 2023